Facebook Twitter Instagram
    Trending
    • Soca Invasion Brings Caribbean Culture to Ghana in January
    • SVG days away from exporting first legal shipment of medicinal cannabis
    • Protect yourself and use condom properly- AIDS Secretariat
    • Bird flu spreads across Europe and Asia
    • 9-year-old dies after Astroworld festival crush, bringing death toll to 10
    • 89-year-old man earns Ph.D. in physics from Brown University
    • 105-year-old runner sets a new 100m world record – but is disappointed she wasn’t even faster
    • Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval
    Magic 103.7
    • HOME
    • NEWS
    • SPORTS
    • ENTERTAINMENT
    • MUSIC / VIDEOS
    • MOVIES / TV
    • TECH
    • POWER HOUSE
    • LIVE
    Magic 103.7
    Home»News»Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval

    Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval

    0
    By Magic 103.7 Admin on November 15, 2021 News

    Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at high risk of progressing to severe illness.” Based on the encouraging results of its trial, Pfizer says it will submit the oral medicine, called Paxlovid, to the U.S. Food and Drug Administration to seek emergency use authorization.

    The pill is similar to Merck’s new pill, which was approved in the United Kingdom last week and is being considered for emergency use by the FDA. Like Merck’s pill, Pfizer said its drug showed promising results when administered within five days of the first COVID-19 symptoms.

    Both of the antiviral medicines from Pfizer and Merck attack COVID-19 by interfering with its ability to replicate itself.

    “These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” said Albert Bourla, chairman and chief executive officer, Pfizer.

    After authorization, Pfizer said its pill could be “prescribed more broadly as an at-home treatment to help reduce illness severity, hospitalizations, and deaths, as well as reduce the probability of infection following exposure, among adults.”

    Pfizer-BioNTech Seek Expansion of FDA Booster Approval for All Individuals 18 and Older

    Pfizer-BioNTech have submitted a request with the U.S. Food and Drug Administration (FDA) to amend its “emergency use authorization” for a booster dose of the company’s COVID-19 vaccine to include all individuals 18 years of age and older.

    The request is based on results from a “Phase 3 randomized, controlled trial evaluating the efficacy and safety” of a booster dose of the vaccine. The study enrolled more than 10,000 participants during a period when the Delta variant was prevalent, Pfizer-BioNTech said in a news release. 

    Results from the trial showed that a booster dose administered to those who previously received the Pfizer-BioNTech primary two-dose series demonstrated “a relative vaccine efficacy of 95 percent when compared to those who did not receive a booster,” the companies stated.

    A booster, or third dose, of the Pfizer-BioNTech COVID-19 Vaccine is now authorized by the FDA for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with “frequent institutional or occupational exposure” to COVID-19.

    Currently, adult recipients of both the Pfizer-BioNTech and Moderna vaccines are eligible for a third shot, or booster, six months after their second injection.

    Source: B Health

    Share this:

    • Click to share on WhatsApp (Opens in new window)
    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Tumblr (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to share on LinkedIn (Opens in new window)
    • Click to share on Reddit (Opens in new window)
    • Click to share on Telegram (Opens in new window)
    • Click to email this to a friend (Opens in new window)
    • Click to print (Opens in new window)

    Related

    Previous ArticleMan asks date for £3.50 back after she says she doesn’t want to meet again
    Next Article 105-year-old runner sets a new 100m world record – but is disappointed she wasn’t even faster

    Leave a Comment Cancel reply

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    • Facebook
    • Twitter
    • Instagram
    • YouTube
    Listen To Magic 103.7 Live

    Trending

    Soca Invasion Brings Caribbean Culture to Ghana in January

    December 9, 2021

    SVG days away from exporting first legal shipment of medicinal cannabis

    December 8, 2021

    Protect yourself and use condom properly- AIDS Secretariat

    December 5, 2021

    Bird flu spreads across Europe and Asia

    November 22, 2021

    9-year-old dies after Astroworld festival crush, bringing death toll to 10

    November 16, 2021
    Magic 103.7 - Today's Music Yesterday's Hits
    Today’s Music Yesterday’s Hits
    Follow Us
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    Popular This Week

    Soca Invasion Brings Caribbean Culture to Ghana in January

    December 9, 2021

    SVG days away from exporting first legal shipment of medicinal cannabis

    December 8, 2021
    Copyright © Magic 103.7 | Designed by Delano Maloney Designs
    • Privacy Policy
    • Contact Us
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.